ATE282022T1 - Amidverbindungen zur stärkung der cholinergischen wirkung - Google Patents

Amidverbindungen zur stärkung der cholinergischen wirkung

Info

Publication number
ATE282022T1
ATE282022T1 AT00902080T AT00902080T ATE282022T1 AT E282022 T1 ATE282022 T1 AT E282022T1 AT 00902080 T AT00902080 T AT 00902080T AT 00902080 T AT00902080 T AT 00902080T AT E282022 T1 ATE282022 T1 AT E282022T1
Authority
AT
Austria
Prior art keywords
strengthen
amide compounds
cholinergic effect
cholinergic
effect
Prior art date
Application number
AT00902080T
Other languages
English (en)
Inventor
Akira Yamada
Satoshi Aoki
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE282022T1 publication Critical patent/ATE282022T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00902080T 1999-02-26 2000-02-03 Amidverbindungen zur stärkung der cholinergischen wirkung ATE282022T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP8912A AUPP891299A0 (en) 1999-02-26 1999-02-26 New 6-membered cyclic compounds
PCT/JP2000/000601 WO2000051970A1 (en) 1999-02-26 2000-02-03 Amide compounds for the potentiation of cholinergic activity

Publications (1)

Publication Number Publication Date
ATE282022T1 true ATE282022T1 (de) 2004-11-15

Family

ID=3813111

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00902080T ATE282022T1 (de) 1999-02-26 2000-02-03 Amidverbindungen zur stärkung der cholinergischen wirkung

Country Status (19)

Country Link
EP (1) EP1159258B1 (de)
JP (1) JP4089159B2 (de)
KR (1) KR100620406B1 (de)
CN (1) CN1170814C (de)
AR (1) AR029618A1 (de)
AT (1) ATE282022T1 (de)
AU (2) AUPP891299A0 (de)
BR (1) BR0010225A (de)
CA (1) CA2371827C (de)
DE (1) DE60015732T2 (de)
DK (1) DK1159258T3 (de)
ES (1) ES2226775T3 (de)
HK (1) HK1044934B (de)
HU (1) HUP0200116A3 (de)
PT (1) PT1159258E (de)
RU (1) RU2211215C2 (de)
TR (1) TR200102494T2 (de)
TW (1) TWI225856B (de)
WO (1) WO2000051970A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030446A1 (en) 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
EP1140105B1 (de) 1998-12-24 2003-10-22 Janssen Pharmaceutica N.V. Galantamin-zusammensetzung mit gesteuerter freisetzung
AR035431A1 (es) 2001-02-13 2004-05-26 Aventis Pharma Gmbh 6,7,8,9-tetrahidro-5h-benzocicloheptenil aminas aciladas, un metodo para su sintesis, composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de medicamentos
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
PE20020856A1 (es) * 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
TWI241190B (en) 2001-02-13 2005-10-11 Aventis Pharma Gmbh 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
AU2003241453A1 (en) 2002-05-17 2003-12-02 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
EP1659881B1 (de) 2003-08-06 2019-04-03 Senomyx Inc. Neue geschmacke, geschmacksmodifikatoren, geschmacksstoffe, geschmacksverstärker, geschmacksstoffe für umami oder süss, und/oder verstärker und ihre verwendung
DK3235811T3 (en) 2006-04-21 2018-11-12 Senomyx Inc PROCEDURE FOR THE PREPARATION OF OXALAMIDS
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AR075401A1 (es) 2009-02-13 2011-03-30 Sanofi Aventis Indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento
JP2025066196A (ja) * 2022-03-14 2025-04-23 国立大学法人東北大学 認知機能改善剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8287M (de) * 1968-12-31 1970-11-09
US4797419A (en) * 1986-11-03 1989-01-10 Warner-Lambert Company Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
EP0306375A1 (de) * 1987-08-07 1989-03-08 Synthelabo 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydrochinolin-Derivate, ihre Herstellung und ihre therapeutische Verwendung
CA1340113C (en) * 1988-05-24 1998-11-03 Magid A. Abou-Gharbia Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
GB8917687D0 (en) * 1989-08-02 1989-09-20 Fujisawa Pharmaceutical Co Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
RU2024507C1 (ru) * 1991-11-18 1994-12-15 Евгений Яковлевич Левитин 5-хлор-2-пиридиламид-4-нитро-n-(карбоксиметил)антраниловой кислоты, проявляющий противовоспалительную активность
JPH06107544A (ja) * 1992-09-29 1994-04-19 Taisho Pharmaceut Co Ltd コリン作動性神経不全の改善・治療薬
JPH06298732A (ja) * 1993-02-16 1994-10-25 Taisho Pharmaceut Co Ltd インドール誘導体

Also Published As

Publication number Publication date
EP1159258A1 (de) 2001-12-05
WO2000051970A1 (en) 2000-09-08
JP4089159B2 (ja) 2008-05-28
PT1159258E (pt) 2005-02-28
AU766655B2 (en) 2003-10-23
RU2211215C2 (ru) 2003-08-27
TR200102494T2 (tr) 2002-01-21
KR100620406B1 (ko) 2006-09-13
EP1159258B1 (de) 2004-11-10
HUP0200116A3 (en) 2002-11-28
AR029618A1 (es) 2003-07-10
BR0010225A (pt) 2002-01-22
HUP0200116A2 (hu) 2002-05-29
TWI225856B (en) 2005-01-01
CA2371827A1 (en) 2000-09-08
HK1044934B (zh) 2005-06-03
DE60015732T2 (de) 2005-03-31
ES2226775T3 (es) 2005-04-01
AUPP891299A0 (en) 1999-03-25
DE60015732D1 (de) 2004-12-16
CN1170814C (zh) 2004-10-13
CA2371827C (en) 2008-06-10
CN1341095A (zh) 2002-03-20
AU2325700A (en) 2000-09-21
HK1044934A1 (en) 2002-11-08
DK1159258T3 (da) 2005-02-14
KR20010102140A (ko) 2001-11-15
JP2002538132A (ja) 2002-11-12

Similar Documents

Publication Publication Date Title
DE60014179D1 (de) Tintenzusammensetzungen
ATE502923T1 (de) Amid-verbindungen
ATE524441T1 (de) Vla-4-inhibitoren
PT1165069E (pt) Composicao sinergistica antitumoral
FI20010683L (fi) Nateglinidiä sisältävä koostumus
IS6798A (is) Atorvastatínhálfkalsíum form VII
NO20016319L (no) VLA-4 inhibitor-forbindelser
ATE295081T1 (de) Hilfsstoff-zusammensetzung
EP1185172A4 (de) Agrochemische zusammensetzng
FI990089L (fi) Maalikoostumukset
DE60015732D1 (de) Amidverbindungen zur stärkung der cholinergischen wirkung
FR2788482B1 (fr) Chariot elevateur
NO20013440D0 (no) Sammensetninger med forbedret stabilitet
DE69902472D1 (de) Zusammemsetzung zum fernhalten von ungeziefer
DK1235566T3 (da) Injicerbar valnemulinformulering
DE60023481D1 (de) Injizierbare zusammensetzung
FI19992609L (fi) Uusi koostumus
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
DE50003014D1 (de) N-substituierte perhydrodiazine
DE60015133D1 (de) Synergistische zusammensetzung von bioziden
IT249583Y1 (it) Filtro per vernici
FI20001769A0 (fi) Kiinnitys
SE9902194D0 (sv) Novel compounds
SE9901270D0 (sv) Novel compounds
SE9902903D0 (sv) Novel compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1159258

Country of ref document: EP

REN Ceased due to non-payment of the annual fee